Mesoblast | MSB - Gross Profit On Sales

Stock Price
2.24
Daily Change
-0.18 -7.44%
Monthly
-17.04%
Yearly
-11.11%
Q1 Forecast
2.36

Mesoblast reported $3.16M in Gross Profit on Sales for its fiscal semester ending in December of 2024.





Gross Profit On Sales Change Date
Avita Medical AUD 14.95M 1.18M Jun/2025
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Cochlear AUD 426.8M 454.9M Jun/2025
CSL USD 1.75B 2.53B Jun/2025
Pacific Edge NZD 5.2M 1.75M Jun/2024
Paradigm Biopharmaceuticals AUD -9K 423.94K Jun/2025
PYC Therapeutics AUD 5.83M 750K Jun/2025
Ramsay Health Care AUD 549.95M 5.77B Jun/2025
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Starpharma Holdings AUD -736K 2.82M Jun/2025
Telix Pharmaceuticals AUD 217.82M 9.23M Dec/2025